Journey Medical Corporation
DERM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $80 | $105 | $34 | $93 |
| - Cash | $20 | $27 | $32 | $49 |
| + Debt | $26 | $18 | $23 | $9 |
| Enterprise Value | $85 | $95 | $25 | $53 |
| Revenue | $56 | $79 | $74 | $63 |
| % Growth | -29.1% | 7.5% | 16.7% | – |
| Gross Profit | $35 | $53 | $43 | $31 |
| % Margin | 62.8% | 66.3% | 58.2% | 49.2% |
| EBITDA | -$8 | $2 | -$23 | -$33 |
| % Margin | -15% | 2.4% | -31.5% | -51.9% |
| Net Income | -$15 | -$4 | -$30 | -$44 |
| % Margin | -26.1% | -4.9% | -40.2% | -69.7% |
| EPS Diluted | -0.72 | -0.21 | -1.69 | -2.54 |
| % Growth | -242.9% | 87.6% | 33.5% | – |
| Operating Cash Flow | -$9 | $5 | -$14 | -$2 |
| Capital Expenditures | -$15 | -$5 | -$20 | -$10 |
| Free Cash Flow | -$9 | $0 | -$34 | -$12 |